This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Moderna Inc. rallied 6.9% to $26.20 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 2.1% to 16,724.46 and the Dow Jones Industrial Average rising 1.6% to 40,212.71.
Moderna Inc. closed 84.6% below its 52-week high of $170.47, which the company reached on May 24th.
The stock outperformed some of its competitors, as Johnson & Johnson rose 2.0% to $151.73, Pfizer Inc. rose 1.5% to $21.91, and Gilead Sciences Inc. rose 2.20% to $103.63.
Trading volume totaled 11.0 million, compared to the 50-day average of 11.3 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 11, 2025 16:32 ET (20:32 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。